| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 7598 | 2017 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 5845* | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3844 | 2018 |
| Effect of three decades of screening mammography on breast-cancer incidence A Bleyer, HG Welch New England Journal of Medicine 367 (21), 1998-2005, 2012 | 1746 | 2012 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 995 | 2022 |
| Breast cancer before age 40 years CK Anders, R Johnson, J Litton, M Phillips, A Bleyer Seminars in oncology 36 (3), 237-249, 2009 | 987 | 2009 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 955 | 2018 |
| The clinical pharmacology of methotrexate. new applications of an old drug WA Bleyer Cancer 41 (1), 36-51, 1978 | 801 | 1978 |
| The distinctive biology of cancer in adolescents and young adults A Bleyer, R Barr, B Hayes-Lattin, D Thomas, C Ellis, B Anderson, ... Nature Reviews Cancer 8 (4), 288-298, 2008 | 747 | 2008 |
| The impact of childhood cancer on the United States and the world WA Bleyer CA: a cancer journal for clinicians 40 (6), 355-367, 1990 | 550 | 1990 |
| The role of clinical trial participation in cancer research: barriers, evidence, and strategies JM Unger, E Cook, E Tai, A Bleyer American Society of Clinical Oncology Educational Book 36, 185-198, 2016 | 547 | 2016 |
| Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma TK Choueiri, P Tomczak, SH Park, B Venugopal, T Ferguson, YH Chang, ... New England Journal of Medicine 385 (8), 683-694, 2021 | 498 | 2021 |
| Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials WA Bleyer Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 2002 | 485 | 2002 |
| Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia WA Bleyer, JC Drake, BA Chabner New England Journal of Medicine 289 (15), 770-773, 1973 | 431 | 1973 |
| Cancer in adolescents and young adults: a narrative review of the current status and a view of the future RD Barr, A Ferrari, L Ries, J Whelan, WA Bleyer JAMA pediatrics 170 (5), 495-501, 2016 | 429 | 2016 |
| Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995 PS Gaynon, ME Trigg, NA Heerema, MG Sensel, HN Sather, ... Leukemia 14 (12), 2223-2233, 2000 | 425 | 2000 |
| Neurologic sequelae of methotrexate and ionizing radiation: a new classification. WA Bleyer Cancer treatment reports 65, 89-98, 1981 | 419 | 1981 |
| Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials A Bleyer, T Budd, M Montello Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 380 | 2006 |
| Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009 RH Johnson, FL Chien, A Bleyer Jama 309 (8), 800-805, 2013 | 374 | 2013 |
| Cancer in 15-to 29-year-olds by primary site A Bleyer, A Viny, R Barr The oncologist 11 (6), 590-601, 2006 | 353 | 2006 |
Peter F Coccia, MDUniversity of Nebraska Medical CenterVerified email at unmc.edu
